Nucleoside aryl phosphoramidates for the treatment of RNA-dependent RNA viral infection
Details for Australian Patent Application No. 2005267421 (hide)
International Classifications
Event Publications
11 January 2007 PCT application entered the National Phase
PCT publication WO2006/012078 Priority application(s): WO2006/012078
28 January 2010 Alteration of Name
The name of the applicant has been altered to Merck Sharp & Dohme Corp.
3 June 2010 Application Accepted
Published as AU-B-2005267421
30 September 2010 Standard Patent Sealed
11 October 2012 Alteration of Name
The name of the patentee has been altered to Merck Sharp & Dohme Corp.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2005267423-Microbial glyphosate resistant 5-enolpyruvylshikimate-3-phosphate synthases
2005267419-Production of valve metal powders with improved physical and electrical properties
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser